Shattuck Labs, Inc. Common Stock (STTK)
PHARMACEUTICAL PREPARATIONS
Shattuck Labs, Inc. Common Stock (STTK) is listed on Nasdaq, where it has traded since October 9, 2020.
- Listed On
- Nasdaq
- Listed Since
- October 9, 2020
- Employees
- 40
- Market Cap
- $583M
About Shattuck Labs, Inc. Common Stock
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 96 institutions reported holding STTK, with 83.8 million shares worth $581.3 million in aggregate. The largest reported holder was T. Rowe Price, with 16.1 million shares worth $111.6 million. Of the 5 largest holders listed below, 4 added shares and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| T. Rowe Price | 16,073,616 | $112M | Added 37.99% |
| Adage Capital Partners GP | 8,122,179 | $56M | Added 74.86% |
| Redmile Group | 6,892,033 | $48M | Added 24.41% |
| Orbimed Advisors | 6,306,127 | $44M | Unchanged |
| Prosight Management | 5,957,877 | $41M | Added 19.05% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is STTK?
Shattuck Labs, Inc. Common Stock (STTK) is listed on Nasdaq, where it has traded since October 9, 2020.
Who are the largest institutional holders of STTK?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of STTK were T. Rowe Price, Adage Capital Partners GP and Redmile Group.
How many institutions own STTK?
96 institutions reported a position in STTK for the quarter ended June 30, 2026, worth $581.3 million in total.
Did institutions buy or sell STTK last quarter?
Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for STTK.
Every reported institutional holder, plus insider and congressional trades in STTK, on SentiSense.